FindTrial
Sign In

The relationship between serum sex hormone level and neurocognitive function among breast cancer women undergoing chemotherapy

The relationship between serum sex hormone level and neurocognitive function among breast cancer women undergoing chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12002807
Enrollment
Unknown
Registered
2012-12-05
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

One:Chemotherapy
2:Nil

Sponsors

Mianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) early stage (clinical I/II) of breast cancer; 2) aged from 18 to 65 years; 3) had a history of cancer; 4) after breast cancer surgery; 5) can understand Chinese.

Exclusion criteria

Exclusion criteria: 1) cancer metastasis; 2) had a history of traumatic brain injury; 3) benign breast lesions; 4) long-term or recent use may cause neurocognitive dysfunction drugs; 5) long-term history of alcohol abuse; 6) comorbidity with hypertension and /or diabetes.

Design outcomes

Primary

MeasureTime frame
Estrogen;Progestin;Androgen;The Montreal cognitive assessment scores;—

Countries

China

Contacts

Public ContactHua-ping Huang
ncocqmu@yahoo.cn+86 15228434339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026